S32

Google’s former Andys—Conrad and Harrison—reunited at VC firm S32, talk AI https://lnkd.in/g5BA89hu

Such a treat to write about computational diagnostics with the one and only Bapu Jena. This piece makes the case that diagnostics are the front door for AI in the clinical care arena - a thesis I’ve believed for a few years now and have seen play out many times over. It also argues that the key bottleneck is financing this entre - and starts to make the case for pharma to play a key role here. h/t to Viz.ai, PathAI, Beacon Biosignals, Caris Life Sciences, and so many other AI diagnostics trailblazers whose pioneering work is featured here. And h/t to Bristol Myers Squibb and other pharmacos that have played a critical role in subsidizing and accelerating the clinical adoption of these tools. Many thanks to the Los Angeles Times for sharing this with the world. https://lnkd.in/ea_gSBZz

Endor Labs has been recognized as Inc's Best Workplaces for 2024! You can't win a Best Workplace award without the best colleagues, customers and partners. The amazing relationships we've built with you has made it possible for us to be the kind of workplace we are today. Congratulations, team. Onwards and upwards! #Hiringnow #AppSec #IncBestWorkplaces

Nusano and PharmaLogic Holdings Corp. Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals: https://lnkd.in/g7ccnTPm #cancer #radiopharmaceuticals #CDMO #supplychain

"They put venture dollars down first and watched how it evolved and started to shake out. Now I think they're more serious about which pieces of the puzzle they want to own as they're starting to see the emerging winners" - Andrew Harrison (S32, CEO) https://lnkd.in/exPvHkfs

TechCrunch thought everyone should know a little bit more about how we're growing and why the #AI control systems in #datacenters we deploy compete directly with "the traditional way of doing things." https://lnkd.in/eQ5XZ_-U

"So do you have the team, the technology, and the set of investors who want to swing for the fence? Or might a double or triple suf­fice? Either path can have a great impact on our nation’s health.” - Michael Pellini (S32, General Partner) https://lnkd.in/gMBqa3WC

Celsius Therapeutics is now part of AbbVie. Learn more and follow AbbVie here: https://lnkd.in/e3nJiUiu

https://lnkd.in/gYUJKRBp

Andrew Harrison (S32 CEO and former Alphabet executive) speaks of the reorganization. “What they did to bring it all under one banner, one set of motivations, was very smart. I think it makes it really clear to the people both inside and outside of Google what the job is,” he says. “And the job is to get the next generation of generative AI techniques in the hands of their customers.” https://lnkd.in/gTuhNB5b